Filtered By:
Source: Neurology

This page shows you your search results in order of date. This is page number 16.

Order by Relevance | Date

Total 3153 results found since Jan 2013.

Rates and Predictors of 1 year of Readmission with Seizures in Patients with Stroke and Stroke Subtypes: Analysis of a National Cohort of 557,033 Stroke Patients (P2.245)
Conclusions:Rate readmission of seizure after stroke within first year is low and there may be residual confounding by severity. Our findings do not support a need for routine prophylactic anti-epileptic drug use after stroke.Disclosure: Dr. Chaudhry has nothing to disclose. Dr. Chaudhry has nothing to disclose. Dr. Afzal has nothing to disclose. Dr. Gheith has nothing to disclose. Dr. Gu has nothing to disclose. Dr. Saeed has nothing to disclose. Dr. Safdar has nothing to disclose. Dr. Kassab has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Chaudhry, B., Chaudhry, S., Afzal, M.-R., Gheith, T., Gu, S., Saeed, A., Safdar, A., Kassab, M., Qureshi, A. Tags: Epilepsy and Clinical Neurophysiology: Clinical Epilepsy II Source Type: research

What are the barriers for use of pharmacological prophylaxis (PP) to prevent deep vein thrombosis (DVT) in spontaneous intracranial bleeding (sICH)? (P2.253)
Conclusions:Following this QI project, we started a new pilot study where DVT prophylaxis advisor was included in all stroke admission orders. The pilot project was successful and DVT prophylaxis advisor is now included permanently to all stroke admission orders including the intracranial hemorrhage. We hope this will ensure patients are started on prophylactic anticoagulation per guidelines.Disclosure: Dr. Jayaraman has nothing to disclose. Dr. Sapnar has nothing to disclose. Dr. Joe has nothing to disclose. Dr. Edara has nothing to disclose. Dr. Yaddanapudi has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Jayaraman, D. K., Sapnar, S., Joe, J., Edara, A., Yaddanapudi, S. Tags: Intracerebral Hemorrhage Source Type: research

Effect Of Insufficient Blood Pressure Control On Intracerebral Hemorrhage Volume In Patients Transferred To A Comprehensive Stroke Center (P2.255)
Conclusions:Poorly controlled BP following ICH transfer to a CSC was associated with increased hematoma volume without worsening overall clinical outcome. Further analysis with a larger sample size may support and expand our observations and lend support to performance improvement initiatives focused on improving BP control at the referring hospital prior to patient transfer.Disclosure: Dr. Tversky has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Tversky, S. Tags: Intracerebral Hemorrhage Source Type: research

To study the impact of chronic vasodilator therapy on perihematomal edema in primary intracerebral hemorrhage(ICH) (P2.259)
Conclusions:Though limited by small sample size, this retro spective study suggests that chronic vasodilator therapy may serve to prevent worsening cerebral edema. This is a tantalizing finding that, if confirmed, could lead to potential pharmacological interventions for patients with ICH. Further prospective studies evaluating the effect of vasodilators in this patient population will be required.Disclosure: Dr. Singh has nothing to disclose. Dr. Albright has nothing to disclose. Dr. Pennington has nothing to disclose. Dr. Gupta has nothing to disclose. Dr. Shapshak has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Singh, M., Albright, K., Pennington, A., Gupta, S., Shapshak, A. H. Tags: Intracerebral Hemorrhage Source Type: research

Exploring the worth of CTA for ICHUsefulness of CT Angiography in the Diagnosis and Treatment of Intracranial Hemorrhage (P2.263)
Conclusions:Routine CTA after CTH provided little benefit in patients with a hypertensive ICH. CTA after non-hypertensive ICH was especially helpful in patients with subarachnoid hemorrhage, where a treatable underlying vascular abnormality was found in 66.7% of patientsDisclosure: Dr. Alchaki has nothing to disclose. Dr. Gomez has nothing to disclose. Dr. E-Ghanmh has nothing to disclose. Dr. Han has nothing to disclose. Dr. Hillen has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Alchaki, A. R., Gomez, F., El-Ghanem, M., Han, H., Hillen, M. Tags: Intracerebral Hemorrhage Source Type: research

Does Race Predict Surgical Feeding Tube Placement In Intracerebral Hemorrhage? (P2.265)
Conclusions:This work represents the largest analysis of ICH patients that required surgical tube feeding. We found no independent association with race as previously reported. Earlier surgical feeding tube placement may reduce hospital length of stay and should be studied further.Disclosure: Dr. Memon has nothing to disclose. Dr. Jackson has nothing to disclose. Dr. Sharrief has nothing to disclose. Dr. Brown has nothing to disclose. Dr. Saeed has nothing to disclose. Dr. Indupuru has nothing to disclose. Dr. DeGuzman has nothing to disclose. Dr. Shoemake has nothing to disclose. Dr. Clayton has nothing to disclose. Dr. C...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Memon, A., Jackson, W., Sharrief, A., Brown, K., Saeed, U., Indupuru, H., DeGuzman, M., Shoemake, P., Clayton, A., Cooper, S., Xavier, A., Cai, C., Vu, K. Y. T., Barreto, A. Tags: Intracerebral Hemorrhage Source Type: research

Utilization of Modified SPAN-100 index in Patients with Intracerebral Hemorrhage: Predictor of Outcomes and Functionality (P2.266)
Conclusions:Modified SPAN-100 index is comparable to ICH score in predicting 30-day mortality, but in terms of functionality the mSPAN is more accurate in predicting the functionality after intracerebral hemorrhage.Disclosure: Dr. Escabillas has nothing to disclose. Dr. Lara has nothing to disclose. Dr. Navarro has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Escabillas, C., Lara, K. J., Navarro, J. Tags: Intracerebral Hemorrhage Source Type: research

Clinical presentation and outcomes of young adults enrolled in the Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study (P2.267)
Conclusions:Young white patients with ICH may have worse outcomes than young black or Hispanic patients. Our results may be limited by selection bias, as enrolled cases are younger and more likely to be black or Hispanic than non-enrolled.Disclosure: Dr. Miyares has nothing to disclose. Dr. Leasure has nothing to disclose. Dr. Kittner has nothing to disclose. Dr. Langefeld has nothing to disclose. Dr. Vagal has nothing to disclose. Dr. Sheth has received personal compensation in an editorial capacity Current Treatment Options in Neurology. Dr. Sheth has received research support from Remedy Pharmaceuticals, Inc. Dr. Woo ha...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Miyares, L., Leasure, A., Kittner, S., Langefeld, C., Vagal, A., Sheth, K., Woo, D. Tags: Intracerebral Hemorrhage Source Type: research

Foley Catheter Use and Infection in Non-Intubated Intracerebral Hemorrhage Patients (P2.269)
Conclusions:Increased duration of Foley catheter exposure among non-intubated ICH patients is associated with higher odds of infectious complications. Efforts should be made to minimize the duration of Foley catheter use among these patients.Disclosure: Dr. Gibson has nothing to disclose. Dr. Albright has nothing to disclose. Dr. Gupta has nothing to disclose. Dr. Boehme has nothing to disclose. Dr. Shapshak has nothing to disclose. Dr. Lyerly has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Gibson, E., Albright, K., Gupta, S., Boehme, A., Shapshak, A., Lyerly, M. Tags: Intracerebral Hemorrhage Source Type: research

Infection is Not Associated with Poor Outcome in Young Adults with Hemorrhagic Stroke (P2.271)
Conclusions:In our single-center study, neither HAI nor infection POA is associated with poor outcomes in young adults with SAH and ICH. This is in contrast to what has been seen previously for ischemic stroke.Disclosure: Dr. Sundheim has nothing to disclose. Dr. Miller has nothing to disclose. Dr. Willey has received personal compensation for activities with Heartware Incoporated as a consultant, from Claret Medical and Reliant Heart as a clinical trial endpoint committee member, and from Up-to-Date as a topic reviewer, Dr. Willey has received personal compensation in an editorial capacity for the the American College of ...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Sundheim, K., Miller, E., Willey, J., Marshall, R., Shao, Y., Boehme, A. Tags: Intracerebral Hemorrhage Source Type: research

Resumption of Antithrombotic Therapy in LVAD-associated Intracranial Hemorrhages (P2.273)
Conclusions:Among survivors of LVAD-associated ICH, those who resumed both antiplatelet plus warfarin therapy had fewer ischemic, but more hemorrhagic events than those who resumed antiplatelet therapy alone.Disclosure: Dr. Cho has nothing to disclose. Dr. Frontera has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Cho, S.-M., Frontera, J. Tags: Intracerebral Hemorrhage Source Type: research

Neuroimaging Characteristics of Intracranial Hemorrhages and Microhemorrhages in Infective Endocarditis (P2.274)
Conclusions:Intracranial macro- or micro-hemorrhages are seen in 73 (63%) persons with IE. The mortality of intracranial hemorrhage is high but the perioperative stroke risk appears low.Disclosure: Dr. Cho has nothing to disclose. Dr. Marquardt has nothing to disclose. Dr. Zhang has nothing to disclose. Dr. Thatikunta has nothing to disclose. Dr. Uchino has nothing to disclose. Dr. Wisco has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Zhang, L., Cho, S.-M., Marquardt, R., Thatikunta, P., Uchino, K., Wisco, D. Tags: Intracerebral Hemorrhage Source Type: research

Off-Hours Emergency Department Arrival Does Not Result in Poor Outcomes Among Intracerebral Hemorrhage Patients Admitted to a Comprehensive Stroke Center (P2.275)
Conclusions:Off-hour admission was not associated with increased risk of infectious complications, length of stay, discharge functional status or discharge disposition. The lack of an off-hours effect in ICH patients may be related to the standardized protocols and available resources found at a CSC. Further studies are needed to confirm these findings in a larger sample.Disclosure: Dr. Gupta has nothing to disclose. Dr. Albright has nothing to disclose. Dr. Gropen has nothing to disclose. Dr. Lyerly has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Gupta, S., Albright, K., Gropen, T., Lyerly, M. Tags: Intracerebral Hemorrhage Source Type: research

Refractory status epilepticus, report from a single center in Saudi Arabia (P2.218)
Conclusions:Less than a third of patients recover well after admission to the intensive care with refractory status epilepticus. About two thirds have stroke or infection as the main cause triggering RSE.Disclosure: Dr. Shafei has nothing to disclose. Dr. Ibrahim has nothing to disclose. Dr. Nughays has nothing to disclose. Dr. Ayoub has nothing to disclose. Dr. Bushnag has nothing to disclose. Dr. Gaweesh has nothing to disclose. Dr. Tashkandi has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Shafei, S., Ibrahim, B., Nughays, R., Ayoub, O., Bushnag, A., Gaweesh, A., Tashkandi, W. Tags: General Neurology: Status Epilepticus and Critical Care Source Type: research

Common etiologies of acute symptomatic seizures evolving from lateralized periodic discharges in patients monitored with continuous EEG (P2.233)
Conclusions:The most common high risk etiologies of acute symptomatic seizures evolving from lateralized periodic discharges in our cohort of patients were ischemic stroke, tumor, encephalitis, and subdural hematoma. Recognition of these etiologic factors may influence the duration of continuous EEG monitoring employed or the decision to institute seizure prophylaxis. A larger cohort of patients should be reviewed in a future study to confirm these findings.Disclosure: Dr. Mathew has nothing to disclose. Dr. Piran has nothing to disclose. Dr. Hantus has received personal compensation for activities with UCB Pharma as a con...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Mathew, S., Piran, P., Hantus, S., Malpe, C. Tags: Epilepsy and Clinical Neurophysiology: EEG and Imaging Source Type: research